Detecting low respiratory rates using myriad, low-cost sensors by Ermer, Sean et al.
2017 Rocky Mountain Space Grant Consortium                                                                                                                     1 
 
Detecting low respiratory rates using myriad, low-cost sensors 
Sean Ermer, B.S., Lara Brewer, Ph.D, Kai Kuck Ph.D, and Joseph Orr, Ph.D 
Department of Bioengineering in Anesthesiology, University of Utah, Utah
 
Abstract: The underlying problem for two of 
the three most common patterns of 
unexpected hospital deaths (PUHD) is 
hypoventilation1. Current methods of post-
operative respiratory monitoring give 
delayed signals and have a high false 
positive rate leading nurses to ignore 
alarms. We hypothesize there exists a 
combination of low cost sensors which are 
capable of providing real time feedback and 
alarms regarding obstructive sleep apnea 
and ventilatory depression. Such a monitor 
would be useful during space travel when 
monitoring personnel are limited following 
an injury or if astronauts were to be sedated 
during extended travel. Methods: Twenty-six 
subjects were recruited to participate in a 
study of the effects of Propofol and 
Remifentanil. Throughout the day, these 
patients were exposed to varying levels of 
both drugs simultaneously via target 
controlled infusions. These patients were 
attached to breathing and oxygen monitors 
including chest bands, pulse oximeters, 
nasal pressure sensors, C02 capnography, 
breathing microphones, and thermistors.  
The patients were then observed for types 
of apnea or ventilatory depression. Results: 
The study is currently ongoing however 
preliminary analyses of the data indicate 
multiple low cost sensors are capable of 
detecting respiratory rate as well as 
obstructive events and apnea. Conclusion: 
Using only a combination of low cost 
sensors, we can provide real time 
respiratory event data to nurses and 
practitioners. 
 
INTRODUCTION & BACKGROUND 
The underlying problem for two of the three 
most common patterns of unexpected 
hospital deaths (PUHD) is hypoventilation1. 
Type II PUHD (CO2 narcosis) involves a 
reduction in respiratory rate and/or tidal 
volume, and if supplemental oxygen is 
being provided, a pulse oximeter will not 
detect the problem until the hypercarbia is 
significantly advanced and the patient is 
near respiratory arrest. Type III PUHD is 
induced by obstructive sleep apnea in the 
presence of arousal failure, and is 
recognized as a repetitive sequence of 
cyclic apneas and self-arousals which 
precede the final apnea. A pulse oximeter 
alarms with each apneic period and will 
likely be interpreted as generating many 
false positive alarms.1 The risk of opioid-
induced respiratory depression in 
postoperative patients is greatest in the first 
24 hours after initiation of opioids2, and 
opioids are the most commonly used drug 
for treating pain in the postoperative 
period.3 
These problems would be especially 
apparent in space travel where monitoring 
personnel are limited due to either sedation 
of crew members or an injury rendering the 
crew short-handed. 
Respiratory depression is caused by drug-
induced inhibition of the breathing control 
center of the brain stem. Partial to full 
airway obstruction is an anatomic problem 
involving the soft palate, tongue base, 
and/or epiglottis, caused by drug-induced 
decreases in airway patency and muscle 
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tone. Sedatives and opioids depress the 
response to elevated CO2 (reduced drive to 
breathe), worsen arousal, cause airway 
obstruction, and change sleep patterns4-8 
In the postoperative period, most adverse 
respiratory events occur during the first 24 
hours of opioid administration.2 During this 
period, pulse oximeter monitoring, 
supplemental oxygen, incentive spirometry, 
and intermittent nursing observation are the 
primary interventions used to fend off 
adverse respiratory events. For inpatient 
monitoring, pulse oximetry is often 
inadequate. On a busy hospital floor, it is 
difficult to respond to multiple remote 
advisory pulse oximetry alarms. Pulse 
oximeter alarms are ignored because they 
have a high false-positive alarm rate due to 
movement artifact and displacement.9,10 
Pulse oximetry primarily monitors 
oxygenation instead of ventilation; the SpO2 
signal is a delayed indicator for apnea or 
hypopnea, particularly when supplemental 
oxygen is given. By the time the pulse 
oximeter alarms, an apneic patient is 
already in danger of hypoxia, brain injury 
and death. 
Existing technologies may improve 
monitoring of adverse respiratory events in 
this setting, but are either costly or difficult 
to implement. For example, monitoring 
ventilation with capnography is expensive 
and it can be problematic to sample the 
exhaled gas with a face mask or nasal 
cannula in non-intubated patients.11 
Acoustic respiratory rate monitoring may be 
able to detect airway obstruction, but it is 
costly and may not have sufficient sensitivity 
to reliably detect apnea events.12 
Additionally, most modern devices have 
been verified for the clinical setting where 
patients are intubated and may not function 
adequately in the non-intubated setting. We 
suggest that there is an urgent need for a 
low cost, reliable respiratory depression 
monitoring technique that can be integrated 
with the signals from the pulse oximeter to 
give additional physiologic information about 
a patient’s sufficiency of both ventilation and 
oxygenation in the non-intubated setting. 
Currently, we are exploring the value of 
integrating the information from a set of low-
cost physiologic monitors that can be 
adapted to monitoring patients in a hospital 
floor setting. In addition to the red and 
infrared component signals that comprise 
the pulse oximeter plethysmography 
waveform, we intend to integrate 
information from respiratory inductance 
plethysmography sensors on the body, 
temperature, pressure and carbon dioxide 
sensors embedded in a nasal cannula and 
acoustic respiratory rate via a microphone 
on the throat. We will determine from the 
tested set the fewest number and least 
costly types of sensors that can be used to 
accurately identify and quantify ventilatory 
depression and airway obstruction, provide 
reliable measures of oxygenation AND 
ventilation, provide specific alarms, and 
avoid artifact. We will evaluate this multi-
sensor set for volunteers who receive 
medications to produce ventilatory 
depression and/or partial to complete airway 
obstruction. 
Our team previously characterized various 
effects of sedatives combined with opioids 
using drug interaction models. Specifically, 
we characterized the interaction of Propofol 
and Remifentanil on metrics of airway 
obstruction and intolerable ventilatory 
depression in volunteers.8 We defined 
intolerable ventilatory depression as a 
respiratory rate less than 6 breaths per 
minute and airway compromise as either 
partial (tidal volume less than 3 mL/kg in the 
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presence of a respiratory effort) or complete 
obstruction. Respiratory compromise was 
defined as either intolerable ventilatory 
depression or airway obstruction or both.  
Using this model, predictions of respiratory 
compromise (0 to 100%) can be made for 
various dosing schemes of Propofol and 
remifentanil.8 (Figure 1).  In general, dosing 
schemes that led to high concentration of 
Propofol were more likely to produce airway 
obstruction and higher doses of 
Remifentanil were more likely to produce 
intolerable ventilatory depression.  
 
 
 
 
 
METHODS 
A 20 gauge venous catheter was placed in 
an antecubital vein under local anesthesia 
(0.2 mL of 0.5% lidocaine) for the purpose 
of hydration and drug administration.  The 
IV site was similar in all subjects. A 
maintenance infusion of 0.9% sodium 
chloride was administered at 1 ml/kg/hour 
throughout the study. Continuous infusions 
of Remifentanil and Propofol was infused 
into this peripheral IV. 
Subjects were instrumented with a 
noninvasive blood pressure cuff, ECG 
leads, pulse oximeter(s), motion sensors, 
respiratory inductance plethysmography 
"chest bands", capnography nasal cannula, 
nasal gas pressure sensor, nasal thermistor 
and an acoustic respiratory rate sensor. 
These or similar monitors were placed to 
measure respiratory rate, tidal volume, end-
tidal CO2, SpO2, blood pressure, body 
motion and heart rate. Chest and abdominal 
wall excursion were measured with the 
attached motion sensors and the respiratory 
inductance plethysmography bands. 
Changes in respiration pattern were 
displayed as real-time changes in CO2 
waveforms. A processed EEG monitor 
and/or a cerebral oximeter were optionally 
placed to record data for later analysis. A 
motion sensor was also placed on the bed. 
These devices were operational during the 
entire study day. Data from devices was 
electronically captured and recorded for 
later analysis. Continuous variables such as 
motion waveforms, pulse oximetry 
waveform, capnogram, and nasal airway 
pressure were digitized during data 
collection periods at 50-1000Hz during data 
collection periods at each target effect site 
concentration pair. Discrete variables were 
recorded every 5 seconds or as soon as 
data were available during data collection 
Figure 1: A: Dose of a drug over time. B: effect 
site concentration (Ce) Corresponding to the 
given dose and C: Observed effect (sedation) for 
a single administered drug. Time points 1-5 
correspond to a different effects on respiration 
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periods. Examples of discrete variables 
include heart rate, SpO2, PetCO2, systolic 
blood pressure, diastolic blood pressure and 
respiratory rate. The tidal volume was 
occasionally measured with a differential 
pressure flow sensor attached to an 
anesthesia mask or mouthpiece in order to 
calibrate the respiratory inductance 
plethysmography bands. 
Each subject received Propofol and 
Remifentanil. Similar to previously collected 
data from our volunteer laboratory (Kern et 
al, 2004), each drug was administered using 
a computer controlled (Stanpump14) 
continuous infusion pump (Pump 22; 
Harvard Apparatus, Limited, Holliston, MA) 
to achieve selected target effect site 
concentrations.  The effect site 
concentration refers to the drug 
concentration at the pharmacologic site of 
action. Pharmacokinetic parameters 
published by Minto et al.15 and Schnider et 
al.16 was used for Remifentanil and Propofol 
respectively. 
We administered Propofol and Remifentanil 
pairs in a dose escalation scheme with 
small steps in order to creep up to the 
desired target effects of respiratory 
depression, airway obstruction and both 
effects while avoiding overshoot. To 
accomplish this, the Propofol was dosed in 
a range of 0.75 - 4 mcg/mL in dose 
escalation steps of approximately 0.5 
mcg/mL. Remifentanil was dosed in a range 
of 0.75 to 4.0 ng/mL in escalation steps of 
approximately 0.25-0.5 ng/mL. If overshoot 
was observed for a given target effect site 
concentration pair, the target effect site 
concentrations were lowered so 
assessments could be made during the 
target effects of respiratory depression or 
airway obstruction or both. Once the drug 
concentration pair was identified which 
resulted in the target effects for a given 
subject, the steady state drug dose was 
maintained for a period of data collection. 
In previous NASA space grant publications, 
a preliminary analysis was performed on 
these sensors which analyzed them for their 
ability to detect obstructive and central 
apneas denoted by a lack of signal. The 
current aim of the project is to detect 
specific breaths in each sensor and use 
these breath marks to analyze periods of 
low respiratory rates. 
A custom breath detection algorithm was 
developed which detects breaths in a signal 
based on peaks which are above or below a 
moving threshold. This algorithm works 
functionally the same for each signal and 
adapts based on specific thresholds which 
were manually identified for each sensor.  
Data were isolated from periods during 
which the patient was unperturbed, not 
talking, and breathing normally (no 
obstruction present). This data was 
segmented into individual minute-by-minute 
segments. Segments which had more than 
10 breaths in them (as counted by the 
respiratory inductance plethysmography 
bands) were excluded from the analysis.  
Bland-Altman and linear regression analysis 
were performed on the data in order to 
analyze the confidence intervals for breath 
rates. A sample Bland-Altman plot for the 
capnogram is shown in figure 2.  
The next analysis involved restricting the 
data set even further to get an estimation of 
how often the alarm would falsely report on 
the patient condition at a clinically relvant 
respiratory rate of 5 or fewer breaths—
commonly diagnosed as ‘ventilatory 
depression’.  
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Each signal was analyzed so that at each 
respiratry rate less than or equal to 10, the 
signal was compared against the reference 
signal (RIP bands) and the number of times 
that the signal was incorrectly diagnosing 
‘ventilatory depression’ was counted.  
An additional endeavor of this data set 
analysis was extracting respiratory rate from 
the photoplethysmography (PPG) signal 
(pulse oximetry). An envelope filter was 
used to obtain the baseline signal (related to 
respiration) from the PPG. The RIP band 
(as the reference respiratory rate signal) 
and the PPG signal were analyzed in order 
to explore the potential for using PPG to 
monitor respiratory rate below 10 breaths 
per minute (BPM). Examples of the filtered 
signal are shown in figures 4, 5, and 6.  
RESULTS 
Figure 2 shows a sample of a Bland-Altman 
analysis performed on the capnogram with 
the RIP bands as the reference signal. The 
signal shows no change in relative bias and 
consistent deviation at all respiratory rates. 
The x-axis represents the mean of 
respiratory rates reported by the capnogram 
and the RIP bands. The y-axis represents 
the difference in the reported respiratory 
rates.  
Table 1 shows the relevant statistics from 
the Bland-Altman analysis not only from the 
capnogram but also from the thermistor and 
impedance signals.   
Figure 3 illustrates an analysis in which 
sections of data were organized by breath 
rate, and the observed percentage of 
misdiagnosis (regarding a RR greater than, 
or less than 5 BPM) was graphed. The 
capnogram illustrated the lowest range of 
misdiagnosis. The error of the impedance 
monitor varied wildly with respiratory rate.   
 
Figure 2: Bland-Altman plot of capnogram reported 
breath rate versus RIP band breath rate. X-axis is the 
mean of the reported breath rates and y-axis is the 
difference (capnogram-RIP bands) in reported breath 
rates. Bias and confidence intervals are depicted by 
the indicated lines. 
 
 
 
Table 2: Bland-Altman statistics from the impedance, 
thermistor, and capnogram monitors. Upper and lower 
confidence intervals are reported as Bias±1.96*STD 
  Capno-
graphy 
Impedance Thermistor 
Bias (BPM) 0.18 0.64 0.51 
Std (BPM) 1.18 3.96 2.09 
Upper 95% 
Confidence 
Interval 
(BPM)  
2.5 8.39 4.61 
Lower 95% 
Confidence 
Interval 
(BPM) 
-2.13 -7.12 -3.58 
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Figure 3: The observed percentage that the 
respiratory rate displayed by a given sensor was in 
error about a low RR (BPM<=5) diagnosis. The right 
side of the black vertical line is the observed 
percentage that a sensor displayed a RR>5 when the 
actual respiratory rate was <=5 (Missed alarm). The 
opposite case (test RR<=5, actual RR>5) (False 
alarm) is shown on the left side of the black vertical 
line.  
 
The error of the thermistor was high around 
5-6 breaths per minute but relatively low 
elsewhere.  
Figure 4 shows an example of an optimal 
case for using the PPG signal to measure 
respiratory rate. In this sample, the breath 
rate is roughly 20 and the filtered PPG 
signal almost exactly mirrors the RIP band 
signal.  
Figures 5 and 6 both illustrate some of the 
issues that arise when trying to use the 
same signal to detect low respiratory rates. 
In both cases, the respiratory rate is 6 or 
less. In figure 5, there is an additional peak 
present between breaths identified by the 
RIP bands. In figure 6, the filtered PPG 
signal demonstrates much more noise than 
the ‘optimal’ case and shows a situation in 
which the PPG signal creates a double-
peak during a single breath identified by the 
RIP bands.  
 
Figure 4: A 20-second window of RIP bands, PPG 
waveform, and an envelope filtered PPG waveform 
are displayed at a RR of 20 BPM. The filtered PPG 
signal modulates in time with inspiration and 
expiration as confirmed by the RIP waveform.  
 
 
Figure 5: A 20-second window of RIP bands, PPG 
waveform, and an envelope filtered PPG waveform 
are displayed at a RR of <5 BPM. The filtered PPG 
waveform changes during the same time period as 
the RIP waveform, but with multiple peaks.  
 
 
Figure 6: A 20-second window of RIP bands, PPG 
waveform, and an envelope filtered PPG waveform 
are displayed at a RR of <5 BPM. The filtered PPG 
signal has deflections between breaths indicated by 
the RIP bands.  
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CONCLUSION 
A low cost, accurate, and minimally sized 
respiratory monitor would be useful during 
space travel when personnel are limited 
following an injury/emergency procedure or 
if astronauts were to be sedated during 
extended voyages.  
The primary goal of this analysis was to 
identify the best way to analyze a signal for 
its clinical utility and to test this analysis on 
some sample signals.  
Figure 3 showed a new method of analyzing 
signals which relies on analyzing the 
number of ‘false alarms’ that a sensor might 
display when monitoring a patient. These 
false alarms were specifically related to 
clinically relevant low respiratory rates. The 
logic behind this is that most monitors will 
perform adequately in the range of ‘normal 
breathing’ but may not perform adequately 
when it comes to raising alarms. The 
capnogram demonstrated that it has the 
ability to distinguish between different 
respiratory rates remarkably well at low 
respiratory rates. The impedance monitor, 
on the other hand, was subject to much 
lower signal-to-noise ratio at these 
respiratory rates and performed poorly with 
respect to properly raising alarms.  
This facet of signals performing differently at 
different respiratory rates is highlighted by 
the case of the PPG signal. At a respiratory 
rate of 20 depicted in figure 4, the PPG 
signal almost perfectly mimics the RIP 
bands (which are used as the reference in 
this study for their relatively high accuracy). 
However when the respiratory rate becomes 
low (less than 6 breaths per minute), the 
signal becomes erratic and much more 
susceptible to noise. A number of 
physiological effects of respiration on the 
bloodstream could be the reasoning behind 
this. One of which is the sympathetically 
mediated vasoconstriction which occurs at 
high tidal volumes. These tidal volumes may 
be more likely when the patient is breathing 
intermittently and the vasoconstriction effect 
may be more pronounced when there is 
less of a respiration signal to mask it. 
We intend to continue this analysis on a 
number of different signals and analyze how 
each signal performs specifically at the 
clinically relevant respiratory rates we are 
hoping to detect. Preliminary analysis 
indicate that multiple sensors may be of use 
in detecting these conditions.   
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